Terms: = Breast cancer AND NONO, Q15233, 4841, ENSG00000147140, NRB54, P54NRB, NMT55, P54 AND Treatment
13 results:
1. VHL suppresses autophagy and tumor growth through PHD1-dependent Beclin1 hydroxylation.
Wang Z; Yan M; Ye L; Zhou Q; Duan Y; Jiang H; Wang L; Ouyang Y; Zhang H; Shen Y; Ji G; Chen X; Tian Q; Xiao L; Wu Q; Meng Y; Liu G; Ma L; Lei B; Lu Z; Xu D
EMBO J; 2024 Mar; 43(6):931-955. PubMed ID: 38360997
[TBL] [Abstract] [Full Text] [Related]
2. Validation of a patient-reported measure of social support provided by nurses in breast cancer care (SuPP-N): based on a cross-sectional patient survey in 83 German hospitals.
Lubasch JS; Lee S; Wirtz MA; Pfaff H; Ansmann L
BMJ Open; 2022 Apr; 12(4):e054015. PubMed ID: 35487734
[TBL] [Abstract] [Full Text] [Related]
3. SPHK1 contributes to cisplatin resistance in bladder cancer cells via the nono/STAT3 axis.
Qin Z; Tong H; Li T; Cao H; Zhu J; Yin S; He W
Int J Mol Med; 2021 Nov; 48(5):. PubMed ID: 34549307
[TBL] [Abstract] [Full Text] [Related]
4. Risk stratification for prediction of locoregional recurrence in patients with pathologic T1-2N0 breast cancer after mastectomy.
Wang J; Tang Y; Jing H; Sun G; Jin J; Liu Y; Song Y; Wang W; Fang H; Chen B; Qi S; Ren H; Li N; Tang Y; Lu N; Yang Y; Yu Z; Wang S; Li Y
BMC Cancer; 2020 Nov; 20(1):1132. PubMed ID: 33228588
[TBL] [Abstract] [Full Text] [Related]
5. Profiling of specific long non-coding RNA signatures identifies ST8SIA6-AS1 AS a novel target for breast cancer.
Chen Z; Huang J; Feng Y; Li Z; Jiang Y
J Gene Med; 2021 Feb; 23(2):e3286. PubMed ID: 33037712
[TBL] [Abstract] [Full Text] [Related]
6. RNA-binding protein nono contributes to cancer cell growth and confers drug resistance as a theranostic target in TNBC.
Kim SJ; Ju JS; Kang MH; Eun JW; Kim YH; Raninga PV; Khanna KK; Győrffy B; Pack CG; Han HD; Lee HJ; Gong G; Shin Y; Mills GB; Eyun SI; Park YY
Theranostics; 2020; 10(18):7974-7992. PubMed ID: 32724453
[TBL] [Abstract] [Full Text] [Related]
7. Long non-coding RNA LINC-PINT attenuates paclitaxel resistance in triple-negative breast cancer cells via targeting the RNA-binding protein nono.
Chen J; Zhu M; Zou L; Xia J; Huang J; Deng Q; Xu R
Acta Biochim Biophys Sin (Shanghai); 2020 Aug; 52(8):801-809. PubMed ID: 32632453
[TBL] [Abstract] [Full Text] [Related]
8. Interfering MSN-nono complex-activated CREB signaling serves as a therapeutic strategy for triple-negative breast cancer.
Qin Y; Chen W; Jiang G; Zhou L; Yang X; Li H; He X; Wang HL; Zhou YB; Huang S; Liu S
Sci Adv; 2020 Feb; 6(8):eaaw9960. PubMed ID: 32128390
[TBL] [Abstract] [Full Text] [Related]
9. Comparison of treatment Outcomes With breast-conserving Surgery Plus Radiotherapy Versus Mastectomy for Patients With Stage I breast cancer: A Propensity Score-matched Analysis.
Wang J; Wang S; Tang Y; Jing H; Sun G; Jin J; Liu Y; Song Y; Wang W; Fang H; Ren H; Yu Z; Li Y
Clin Breast Cancer; 2018 Oct; 18(5):e975-e984. PubMed ID: 30054238
[TBL] [Abstract] [Full Text] [Related]
10. Study on the expression of PAK4 and p54 protein in breast cancer.
Bi Y; Tian M; Le J; Wang L; Liu X; Qu J; Hao M
World J Surg Oncol; 2016 Jun; 14(1):160. PubMed ID: 27297086
[TBL] [Abstract] [Full Text] [Related]
11. Transforming growth factor-β1 attenuates junctional adhesion molecule-A and contributes to breast cancer cell invasion.
Wang Y; Lui WY
Eur J Cancer; 2012 Dec; 48(18):3475-87. PubMed ID: 22647687
[TBL] [Abstract] [Full Text] [Related]
12. Nitric oxide enhancement of melphalan-induced cytotoxicity.
Cook JA; Krishna MC; Pacelli R; DeGraff W; Liebmann J; Mitchell JB; Russo A; Wink DA
Br J Cancer; 1997; 76(3):325-34. PubMed ID: 9252199
[TBL] [Abstract] [Full Text] [Related]
13. Interaction of the progesterone receptor with binding proteins for FK506 and cyclosporin A.
Milad M; Sullivan W; Diehl E; Altmann M; Nordeen S; Edwards DP; Toft DO
Mol Endocrinol; 1995 Jul; 9(7):838-47. PubMed ID: 7476967
[TBL] [Abstract] [Full Text] [Related]
